Edition:
India

China NT Pharma Group Co Ltd (1011.HK)

1011.HK on Hong Kong Stock

1.77HKD
23 Feb 2018
Change (% chg)

HK$-0.01 (-0.56%)
Prev Close
HK$1.78
Open
HK$1.79
Day's High
HK$1.79
Day's Low
HK$1.76
Volume
30,000
Avg. Vol
1,248,077
52-wk High
HK$2.22
52-wk Low
HK$1.53

Latest Key Developments (Source: Significant Developments)

China NT Pharma says co entered into asset purchase agreement with Novartis<1011.HK>
Wednesday, 18 May 2016 

China NT Pharma Group Co Ltd <1011.HK>: NT Pharma (as purchaser) entered into asset purchase agreement with Novartis . Purchase price would be in the aggregate sum of US$145 million . Co has made an application for the resumption of trading in the shares of co with effect from 9:00 a.m. on Thursday, 19 May 2016 .  Full Article

China NT Pharma says trading halted pending release of announcement regarding signed agreements of acquisition<1011.HK>
Wednesday, 18 May 2016 

China NT Pharma Group Co Ltd <1011.HK>: Trading halt . Seeks trading halt pending release of announcement in relation to signed agreements of acquisition of pharmaceutical assets .  Full Article

China NT Pharma Group Co Ltd says in discussions regarding acquisition of pharmaceutical assets
Tuesday, 5 Apr 2016 

China NT Pharma Group Co Ltd:Voluntary announcement potential acquisition.Company is in discussions with an independent third party regarding the potential acquisition of pharmaceutical assets.Company has not entered into any definitive agreement in relation to the potential acquisition.As at date of announcement, no material terms concerning potential acquisition have been agreed.  Full Article

BRIEF-China Nt Pharma Group Co Says Co To Cease Libod Sales & Promotion From Dec. 31, 2017

* ENTERS DEAL TO TERMINATE SALES & PROMOTION DEAL, CO TO CEASE LIBOD SALES & PROMOTION FROM DEC. 31, 2017 Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)